Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Common Stock | Options Exercise | +2.62K | +2.43% | 110K | Sep 10, 2023 | Direct | F1 | ||
transaction | GILD | Common Stock | Tax liability | -$91.4K | -1.2K | -1.09% | $76.00 | 109K | Sep 10, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Restricted Stock Unit | Options Exercise | -2.62K | -5.7% | 43.4K | Sep 10, 2023 | Common Stock | 2.62K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
F2 | The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |